Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnSquareMore

News

Stay up to date on the latest crypto trends with our expert, in-depth coverage.

banner
All
Crypto
Stocks
Commodities & Forex
Macro
Flash
15:22
Staking service provider P2P.org appoints former Citigroup executive Betsabe Botaitis as CFO
Foresight News reports that, according to Fortune magazine, institutional crypto staking infrastructure provider P2P.org has announced the appointment of Betsabe Botaitis as its new Chief Financial Officer. Betsabe Botaitis previously worked at Citigroup and LendingClub, and has many years of experience in financial data strategy and AI applications. Founded in 2018, P2P.org provides banks, exchanges, digital wallets, and custodians with validator, server, and security system support for more than 40 blockchain networks including Ethereum and Solana, assisting institutional clients in earning staking rewards without the need to build their own systems.
15:15
Trump: Iran Agrees to 'Everything'
On April 17, Trump told NewsNation that Iran has agreed to 'everything.' Iran has agreed not to close the Strait of Hormuz again, which will no longer be used as a weapon against the world. Iran has also agreed to stop enriching uranium. As of the time of publication, crude oil prices had dropped over 12%, and European gas prices fell by 10% following President Trump's remarks about the Strait of Hormuz.
15:15
Kidney cancer drug data update shows improvement, Kura stock rises
Previously, the company released preliminary subgroup analysis data on the combination treatment of darlifarnib and cabozantinib for patients with clear cell renal cell carcinoma (ccRCC) who had previously been treated with cabozantinib. According to a statement, the relevant results are from the ongoing FIT-001 clinical trial: Subgroup analysis data on patients previously treated with cabozantinib supported the potential of this therapy to overcome resistance. Tumor reduction was observed in 75% of patients. Across multiple dose levels, all renal cell carcinoma (RCC) patients demonstrated manageable safety and tolerability characteristics.
News